Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2NET 1Head & Neck 1Endocrine 1Dermatologic 1CNS 1Breast 1

Conditions

Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 6Nasopharyngeal Carcinoma 4Ovarian Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Recurrence 2Penile Neoplasms 2Neoplasms 2Hodgkin Disease 2Carcinoma, Squamous Cell 2Anus Neoplasms 2Uveal Melanoma 1Thyroid Neoplasms 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Pheochromocytoma 1Paraganglioma 1Papillomavirus Infections 1Neuroendocrine Tumors 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 3tislelizumab 1spartalizumab 1fludarabine phosphate 1bemarituzumab 1Tablets 1Specimen Handling 1Solutions 1Rogaratinib 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Interleukin-13 1IFL protocol 1Fluorodeoxyglucose F18 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Biopsy 1BID protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × fludarabine phosphate × Head & Neck × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡